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Chemists continue to seek methods to assemble saturated
nitrogen heterocycles to exploit pharmacological potential.[1]
We have an ongoing interest in the preparation of pyrrolo-
ACHTUNGTRENNUNG[1,2-a]imidazoles by diastereoselective 1,3-dipolar cycloaddi-
tion of 4,5-dihydroimidazolium ylides 1, formed in situ from
dihydroimidazoles, an alkylating agent, and base,[2] or more
recently by carbenoid insertion onto the dihydroimidazole
N(1) lone pair.[3] We have elaborated these primary cycload-
ducts to produce pyrrolidines, pyrrolizidines, indolizidines,[4]
and (by intramolecular cycloaddition) imidazo ACHTUNGTRENNUNG[1,2-a]indoles
which can undergo cascade conversion into pyrroloACHTUNGTRENNUNG[1,2,3-
de]quinoxalines.[5] Cycloaddition of optically active ylides
produces optically active pyrrolidines via pyrrolo ACHTUNGTRENNUNG[1,2-a]imi-
dazoles, exemplified in Scheme 1.[6] 4,5-Dihydroimidazole
(2-imidazoline) derivatives display a range of pharmacologi-
cal properties; pyrroloACHTUNGTRENNUNG[1,2-a]imidazoles have themselves re-
cently been investigated as JNK3 inhibitors.[7]
When assembling reduced heterocycles, it is clearly of
great importance to be able to predict the stereochemical
outcome. In all of the cases reported to date, the dipolaro-
phile is an electron-deficient alkene activated by a carbonyl
group, usually an ester, or by a nitrile, that is, by a planar
sp2 or a linear sp carbon atom, and the diastereoselectivity
shown by the major (and in most cases the only) cycload-
duct is consistent with the transition-state model of Figure 1,
involving an anti dipole and an endo approach by the dipo-
larophile.[2,8] With a view to de-
veloping a traceless dipolaro-
phile activation,[9] we have in-
vestigated potentially remova-
ble sulfur-containing activating
groups, principally sulfone. We
report herein the results of cy-
cloadditions using a range of
vinyl sulfones, the unexpected
stereochemical outcomes ob-
served, and a new secondary re-
action of the cycloadducts.
Initial studies employed 1-
benzyl-4,5-dihydroimidazole 2a, using our previously report-
ed one-pot protocol.[2] Thus the dihydroimidazole, alkylating
agent, and dipolarophile (3 mol equiv of dipolarophile) were
mixed in THF at reflux and DBU was added dropwise over
4 h. Using tert-butyl bromoacetate and phenyl vinyl sulfone,
cycloadduct 3a was isolated (45%) after column chromatog-
raphy and recrystallization (Scheme 2). In contrast to our
previous reports with carbonyl- and nitrile-activated dipolar-
ophiles, pyrrolo ACHTUNGTRENNUNG[1,2-a]imidazole 3a results from the unex-
pected exo approach of the dipolarophile to the dipole. This
was indicated by a nuclear Overhauser effect (n.O.e.) inves-
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Scheme 1. Dihydroimidazolium ylides in pyrrolidine synthesis. Reagents:
i) BrCH2X, RCH=CHY, DBU; ii) NaBH3CN, H
+ ; iii) Pd(OH)2, H2.
Figure 1. Transition-state
model for dihydroimidazolium
ylide endo cycloaddition
(Scheme 1) where Y=ester,
ketone, nitrile, i.e., sp2 or sp
activating group.
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tigation, which demonstrated, for example, enhancement at
C(5)-H on irradiation at C(7)-H, that is, a cis relationship
between C(5) and C(7) substituents, and was confirmed by
an X-ray crystal structure determination (Figure 2). We
speculate that the extra steric requirement of the tetrahedral
sulfone moiety may overcome any secondary orbital interac-
tions that favor an endo approach for sp2 activating groups.
Further examples of the cycloadducts of 2a with phenyl
vinyl sulfone were added using ethyl bromoacetate, methyl
bromoacetate, and bromoacetonitrile to afford pyrroloimi-
dazoles 3b–d, and these results are summarized in Table 1.
The dipolarophile was replaced by methyl vinyl sulfone to
afford cycloadducts 3e, f using tert-butyl and methyl bro-
moacetate as alkylating agents, respectively, and by phenyl
vinyl sulfoxide to afford 3g using tert-butyl bromoacetate as
an alkylation partner. The dihydroimidazole component
could be replaced by 1-phenyl-4,5-dihydroimidazole 2b to
afford cycloadducts 3h–j of phenyl vinyl sulfone using tert-
butyl, ethyl, and methyl bromoacetate, respectively, and
3k, l with methyl vinyl sulfone and phenyl vinyl sulfoxide,
respectively, using tert-butyl bromoacetate. Although the
yields were moderate, no other cycloadducts (isomers) were
isolated.
The adducts 3a–f,h–l shown in Table 1 all displayed the
same relative stereochemistry as seen in 3a, that is, exo cy-
cloaddition (Figure 3).[10] This
finding was supported in each
case by extensive n.O.e. studies.
For example, N-phenyl adduct
3h showed enhancement of
C(5)-H as well as one of C(6)-
H on irradiation of C(7)-H, and
irradiation of C(5)-H showed
the reciprocal enhancements;
no enhancement of bridgehead
proton C(7a)-H was observed.
Further X-ray crystal structures
were obtained for 3e (Figure 4)
and the N-phenyl derivative 3k (Figure 5). In the latter case,
two independent molecules were observed in the unit cell,
both having the same relative stereochemistry but differing
in exact conformation, and just one is illustrated in Figure 5.
The sulfoxide cycloadduct 3g was obtained as an insepara-
ble 1:1 stereoisomer mixture which, based on all the other
results in Table 1, we tentatively assume to be due to the
sulfoxide stereocenter; the isolation of 3 l as one (exo) dia-
stereomer is, we assume, due to a selective crystallization.
Interestingly, in the cases of the methyl bromoacetate cy-
cloadducts 3c, f, j, second products were isolated (15, 5, and
Scheme 2. Exo dipolar cycloadditions of achiral dihydroimidazoles 2 with
sulfur-activated dipolarophiles. Reagents: i) BrCH2X, CH2=CHY, DBU.
Figure 2. X-ray crystal structure of 3a (enantiomer, crystallographic num-
bering).
Table 1. Exo dipolar cycloadditions of achiral dihydroimidazoles 2 with
sulfur-activated dipolarophiles.
Dipolarophile Alkylating
agent
Adducts 3 from di-
hydroimidazole 2a
(R=CH2Ph) (Yield)
Adducts 3 from di-
hydroimidazole 2b
(R=Ph) (Yield)
CH2=CHSO2Ph BrCH2CO2tBu 3a (45%) 3h (55%)
CH2=CHSO2Ph BrCH2CO2Et 3b (18%) 3 i (29%)
CH2=CHSO2Ph BrCH2CO2Me 3c (12%) 3j (25%)
CH2=CHSO2Ph BrCH2CN 3d (25%)
CH2=CHSO2Me BrCH2CO2tBu 3e (37%) 3k (57%)
CH2=CHSO2Me BrCH2CO2Me 3 f (10%)
CH2=CHSOPh BrCH2CO2tBu 3g (26%) 3 l (22%)
Figure 3. Transition-state
model for dihydroimidazolium
ylide endo cycloaddition
(Scheme 2) to give adducts 3 ;
Y= sulfone or sulfoxide.
Figure 4. X-ray crystal structure of 3e (crystallographic numbering).
&2& www.chemasianj.org  2010 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim Chem. Asian J. 0000, 00, 0 – 0&&
 These are not the final page numbers!
COMMUNICATION
15%, respectively) displaying an extra methoxy signal in
their 1H NMR spectra, which were shown to be the eight-
membered ring compounds 4a–c, respectively. The structure
of 4a was confirmed by an X-ray crystal structure determi-
nation (Figure 6). We propose that 4a–c arise from alkyla-
tion of the bridgehead nitrogen atom of primary cycload-
ducts 3c, f, j followed by Hoffman-type b-elimination
(Scheme 3) to give the cyclic (E)-alkene.
With all the achiral dihydroimidazole sulfone and sulfox-
ide-substituted adducts 3 showing the unexpected exo cyclo-
addition mode, we investigated reactions of the chiral 4-
phenyl-4,5-dihydroimidazoles 5a–c. Using first the 1-benzyl-
dihydromidazole 5a and phenyl vinyl sulfone, pyrroloimida-
zoles 6a–c were isolated using tert-butyl, ethyl, and methyl
bromoacetates as alkylating agent (Scheme 4, Table 2). We
were surprised to find that these cycloadducts were now in
the endo series. Thus 6a showed n.O.e. enhancements at
C(7)-H, but not at C(5)-H, on irradiation of bridgehead
C(7a)-H. Irradiation of C(7)-H produced enhancement of
C(7a)-H and one proton at C(6), but again not of C(5)-H.
Finally, irradiation of C(5)-H showed enhancement of the
other proton at C(6), as well as C(3)-H. This demonstrates
the trans relationship of the C(5) and C(7) substituents, also
the cis relationships of C(3) and C(5) substituents, and of
C(7)-H with C(7a)-H. The relative stereochemistries of 6a, c
were each confirmed by X-ray crystal structure determina-
tion (Figures 7 and 8, respectively).
Further examples 6d,e of pyrrolo ACHTUNGTRENNUNG[1,2-a]imidazoles from
chiral dihydroimidazole 5a were obtained by using methyl
Figure 5. X-ray crystal structure of 3k (enantiomer, crystallographic num-
bering, one of two similar molecules in the asymmetric unit).
Figure 6. X-ray crystal structure of 4a (crystallographic numbering).
Scheme 3. Secondary transformation of cycloadducts 3c, f, j. Reagents:
i) BrCH2CO2Me.
Scheme 4. Endo dipolar cycloadditions of chiral dihydroimidazoles 5 with
sulfur-activated dipolarophiles. Reagents: i) BrCH2X, CH2=CHY, DBU.
Table 2. Endo dipolar cycloadditions of chiral dihydroimidazoles 5 with
sulfur-activated dipolarophiles.
Dipolarophile
CH2=CHY;
Y=
Alkylating
agent
BrCH2X;
X=
Adducts 6
from 5a
(R=CH2Ph)
(Yield)
Adducts 6
from 5b
(R=Ph)
(Yield)
Adducts 6
from 5c
(R=Me)
(Yield)
SO2Ph CO2tBu 6a (28%) 6 f (19%) 6h (22%)
SO2Ph CO2Et 6b (25%) 6 i (16%)
SO2Ph CO2Me 6c (19%) 6g (25%) 6j (10%)
SO2Me CO2tBu 6d (25%)
[a] 6k (19%)
SO2Me CO2Me 6e (12%) 6 l (12%)
[a] 6d is exo adduct, i.e., epimer at C(7).
Chem. Asian J. 2010, 00, 0 – 0  2010 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim www.chemasianj.org 3& &&
These are not the final page numbers! 
An Unexpected Stereochemical Course of Dihydroimidazolium Ylide Cycloadditions
vinyl sulfone and tert-butyl or methyl bromoacetate. Replac-
ing the 4-phenyldihydroimidazole by the N-phenyl deriva-
tive 5b led to adducts 6 f,g from phenyl vinyl sulfone with
tert-butyl and ethyl bromoacetate, respectively. Finally, N-
methyldihydroimidazole 5c gave cycloadducts 6h–j using
phenyl vinyl sulfone with tert-butyl, ethyl, and methyl bro-
moacetate, and 6k, l from methyl vinyl sulfone with tert-
butyl and methyl bromoacetate, respectively. Yields of these
cycloadducts are unoptimized, but no other cycloadducts
(isomers) were isolated.
In all cases except one, endo adducts were the only ob-
served cycloaddition products. The exception was 6d, where
an exo relative configuration was revealed by an X-ray crys-
tal structure determination (not illustrated). We have no ra-
tionale for this exception. No secondary eight-membered
ring products were observed, possibly because the 3-phenyl
substituent in the primary adducts 6 restricted access to the
bridgehead nitrogen atom by a further alkylating agent.
We have therefore observed an unexpected switch of cy-
cloaddition mode from endo to exo for sulfone-activated di-
polarophiles with achiral dihydroimidazolium ylides that
may be related to the extra steric requirement of tetrahedral
sulfur activating groups. This did not occur for chiral dihy-
droimidazoles, with just one exception amongst the exam-
ples reported. The cycloaddition mode should not affect the
search for traceless activation via post-cycloaddition CS
bond cleavage, nor functionalization a to the sulfone group,
which should proceed via a planar carbanion.[11] Work in
these directions is ongoing.
Experimental Section
General procedure for dipolar cycloadditions, exemplified for 1-benzyl-5-
tert-butoxycarbonyl-7-phenylsulfonylhexahydropyrrolo ACHTUNGTRENNUNG[1,2-a]imidazole
(3a ; data for other compounds are provided in the Supporting Informa-
tion): 1-Benzyl-4,5-dihydroimidazole 2a (1.02 g, 6.38 mmol), tert-butyl
bromoacetate (1.00 mL, 6.38 mmol), and phenyl vinyl sulfone (3.29 g,
19.14 mmol) in freshly distilled THF (30 mL) were placed in a three-
necked round-bottom flask and heated to reflux under nitrogen. DBU
(10.98 mL, 6.38 mmol) was then added to the reaction mixture using a sy-
ringe pump over 4 h, and the reaction was heated under reflux for a fur-
ther 2 h, at which point the reaction mixture was cooled to room temper-
ature and evaporated under reduced pressure. The residue was treated
with water (30 mL), extracted with chloroform (330 mL), and the com-
bined organic layers were dried (Na2SO4), filtered, and evaporated under
reduced pressure to a dark viscous oil. The product was purified by
column chromatography on silica gel (Merck Kieselgel 60H), eluting
with hexane/ethyl acetate (7:3 v/v) to afford a white solid. The solid still
contained some phenyl vinyl sulfone, however triturating with a mini-
mum amount of propan-2-ol gave the title compound as a white solid
(1.21 g, 45%); m.p. 145.5–146.7 8C (found: C 65.13, H 6.82, N 6.42, MH+
443.201; C24H30N2O4S requires C 65.13, H 6.83, N 6.33, MH
+ 443.200);
n˜max ACHTUNGTRENNUNG(film)=1737 (C=O), 1306 (S=O), 1147 cm
1 (S=O); 1H NMR
(400MHz; (CD3)2SO): 1.40 (9H, s, C ACHTUNGTRENNUNG(CH3)3), 2.21-2.33 (3H, m,
NCHHCH2N and CHCH2), 2.70-2.75 (1H, m, NCH2CHHN), 2.78-2.82
(1H, m, NCHHCH2N), 2.96 (1H, d, J = 13.0 Hz, PhCHH), 2.99-3.02
(1H, m, NCH2CHHN), 3.44 (1H, dd, J = 6.8 and 9.9 Hz, CHCH2), 3.61
(1H, d, J = 13.0 Hz, PhCHH), 3.98-4.04 (2H, m, CHSO2 and C(7a)-H)
and 7.18-8.00 ppm (10H, m, Ar-H); 13C NMR (100MHz; (CD3)2SO): 27.6
(C ACHTUNGTRENNUNG(CH3)3), 30.7 (CHCH2), 50.8, 51.2 (2 x NCH2), 55.0 (PhCH2), 65.8
(CHSO2), 67.0 (CHCH2), 80.5 (C ACHTUNGTRENNUNG(CH3)3), 85.2 (C-7a), 126.8, 128.1, 128.4,
128.5, 129.6, 136.3 (6 x Ar-CH), 137.8, 138.7 (2 x Ar-C), 170.3 ppm (C=
O); m/z 443 [MH+], 387, 274, 91.
Crystal data were collected on a Bruker SMART 1000 CCD diffractome-
ter using narrow slice 0.38 w scans for 3e, 3k, and 4a[12] (Bruker APEX 2
for 3a, 6a, 6c, and 6d). Data for 3a were collected at Daresbury Labora-
tory SRS Station 9.8 using silicon 111 monochromated X-radiation.[12]
Data were corrected for Lp effects and for absorption, based on repeated
and symmetry equivalent reflections, and solved by direct methods.[13,14]
Structures were refined by full matrix least squares on F2.[13,14] H atoms
were included in a riding model. Hydrogen atom Uiso values were con-
strained to be 120% of that of the carrier atom except for methyl-H
(150%). Crystallographic data are provided in the Supporting Informa-
tion; CCDC 747655, CCDC 747656, CCDC 747657, CCDC 747658,
CCDC 747659, CCDC 747660, CCDC 747661 contain the supplementary
crystallographic data for this paper, for 3a, 3e, 3k, 4a, 6a, 6b, 6c, 6d.
These data can be obtained free of charge from The Cambridge Crystal-
lographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
Figure 7. X-ray crystal structure of 6a (enantiomer, crystallographic num-
bering).
Figure 8. X-ray crystal structure of 6c (enantiomer, crystallographic num-
bering).
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An Unexpected Stereochemical
Course of Dihydroimidazolium Ylide
Cycloadditions
Turning the tables : We have observed
an unexpected switch of cycloaddition
mode from endo to exo for sulfone-
activated dipolarophiles with achiral
dihydroimidazolium ylides to produce
pyrrolo ACHTUNGTRENNUNG[1,2-a]imidazoles, that may be
related to the extra steric requirement
of tetrahedral sulfur activating groups.
This did not occur for chiral dihydroi-
midazoles, with just one exception
amongst the examples reported.
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